When it comes to evidence-based treatment for dermatillomania, the research base is smaller than for conditions like OCD or depression, but it is growing. One of the most significant studies in the field is the SaveMySkin randomised controlled trial, published in 2019 by Gallinat and colleagues in JMIR Mental Health. It is notable not just for its findings but for what it demonstrated: that a structured self-help programme, delivered digitally and without a therapist present, can produce large, clinically meaningful reductions in skin picking severity.
The SaveMySkin study was a pilot randomised controlled trial, the pilot designation is important, and we return to it below. It compared a structured digital self-help intervention against a waitlist control group. Participants were adults with clinically confirmed dermatillomania. They were not restricted to people who had already sought treatment, which makes the sample more representative of the broader population living with the condition.
Authors: Gallinat, Hund, Knauth, & Sliwinski (2019)
Published: JMIR Mental Health
Design: Pilot randomised controlled trial with waitlist control
Participants: 133 adults with dermatillomania enrolled; 38 completers
Intervention: Structured digital self-help programme based on CBT techniques
Primary outcome measure: Skin Picking Scale-Revised (SPS-R), a validated self-report scale measuring picking frequency, urge intensity, distress, and functional impairment
The SaveMySkin programme was a CBT-based (cognitive-behavioural therapy) digital intervention. It had four components:
There was no hypnosis or any hypnotherapy component in the SaveMySkin programme. It was a structured CBT-based self-help intervention, delivered digitally.
The results provided strong evidence for the effectiveness of the structured self-help approach. Compared to the waitlist control group, participants in the intervention condition showed statistically and clinically significant improvements across the primary and secondary outcome measures.
An effect size of d = 0.79 is considered large in clinical research. For context, the typical effect size for antidepressants in treating depression is approximately d = 0.30 to 0.40. The SaveMySkin results represent a clinically meaningful intervention for a condition that has no approved pharmaceutical treatment.
Effect size is a measure of how meaningful an improvement is, not just whether it reached statistical significance. A large effect size means the difference between the intervention and the control group was substantial enough to matter in a person's daily life, not just large enough to show up in a spreadsheet.
For a self-help programme, without a therapist, without clinic appointments, accessible privately at home, to produce effect sizes in this range is significant. It suggests that the quality and structure of the intervention matters more than whether it is delivered face-to-face or digitally.
The word pilot in the study title is not a minor caveat. A pilot RCT is an exploratory study, designed to test whether a full-scale trial is feasible and to identify what the effect sizes might be. It was not powered to provide definitive proof of efficacy. The authors themselves noted the study's limitations: the relatively high dropout rate (only 38 of 133 participants completed the programme), the self-selected sample of adults who were motivated enough to enrol, and the absence of long-term follow-up data.
This means the 74% satisfaction figure, the 92% appropriateness rating, and even the effect sizes should be understood as findings from a well-designed exploratory study, promising and directionally meaningful, but not a definitive clinical proof. The researchers called for larger, fully-powered trials with longer follow-up periods. To date, the SaveMySkin pilot remains the most methodologically rigorous study specifically testing a digital self-help programme for dermatillomania, which is why it holds its place as a key reference point, while its limitations should be acknowledged alongside its findings.
The most important implication of the SaveMySkin trial is that dermatillomania can be meaningfully addressed through a well-designed self-help programme, without specialist access. This matters given the gap between how common the condition is (approximately 1 in 20 people) and how rarely people receive any specialist support for it.
It also matters because of the shame that typically surrounds skin picking. Many people who would not see a therapist or tell their GP are willing to work through a structured programme privately. If the evidence shows that such a programme can produce large effect sizes, the accessibility of the format becomes an advantage, reaching people who would otherwise receive nothing.
The study does not guarantee any individual outcome, and recovery is rarely linear. But it is one of the clearest evidence foundations available for structured self-help as a meaningful approach to dermatillomania treatment.
Learning about your skin picking makes a real difference both on the inside and outside, with that awareness creating a ripple effect. If you're ready to explore a compassionate guide to kick-start your picking management, start here.